Very Late Stent Thrombosis in a Drug-Eluting Stent due to Interruption of Anti-Platelet Agents in Patients With Acute Myocardial Infarction and Thrombocytosis.
10.4070/kcj.2011.41.7.417
- Author:
Hong Sang CHOI
1
;
Myung Ho JEONG
;
Il Kook SEO
;
Min Goo LEE
;
Jum Suk KO
;
Keun Ho PARK
;
Doo Sun SIM
;
Nam Sik YOON
;
Kye Hun KIM
;
Hyung Wook PARK
;
Young Joon HONG
;
Ju Han KIM
;
Youngkeun AHN
;
Jeong Gwan CHO
;
Jong Chun PARK
;
Jung Chaee KANG
Author Information
1. The Heart Center of Chonnam National University Hospital, Cardiovascular Research Institute of Chonnam National University, Gwangju, Korea. myungho@chollian.net
- Publication Type:Case Report
- Keywords:
Drug-eluting stents;
Thrombosis;
Essential thrombocythemia
- MeSH:
Drug-Eluting Stents;
Humans;
Myocardial Infarction;
Percutaneous Coronary Intervention;
Risk Factors;
Stents;
Thrombocythemia, Essential;
Thrombocytosis;
Thrombosis
- From:Korean Circulation Journal
2011;41(7):417-420
- CountryRepublic of Korea
- Language:English
-
Abstract:
Stent thrombosis is a fatal complication in patients who have undergone percutaneous coronary intervention, and discontinuation of anti-platelet agent is a major risk factor of stent thrombosis. We report a rare case of very late stent thrombosis (VLST) following discontinuation of anti-platelet agents in a patient who experienced acute myocardial infarction and essential thrombocytosis. She had undergone implantation of a drug eluting stent (DES) and a bare metal stent (BMS) two and half years prior to her presentation. VLST developed in DES, not in BMS, following interruption of anti-platelet therapy.
